Katherine S Zanotti Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 weeks, 4 days ago
Katherine S Zanotti has an estimated net worth of at least $10.5 million*, as of March 18, 2026. They own 24,796 shares of EXAS stock. They have sold 25,309 shares of EXAS stock since 2021, for an estimated $1.6 million.
Katherine S Zanotti $EXAS SEC Form 4 Insider Trading
Katherine S Zanotti has filed a total of 6 insider trades in $EXAS since 2021. Their most recent trade was a sale of 12,000 shares, made on Oct 24, 2025. Their largest trade was a sale of 12,000 shares, made on Oct 24, 2025. We estimate that they now own 24,796 shares of $EXAS, worth an estimated $8.9 million.
Insider Trading at $EXAS
There have been a total of 150 insider trades reported at $EXAS since 2021, with 19,500 shares purchased and 559,166 shares sold. The most active insider traders in $EXAS stock have been Jeffrey Thomas Elliott, Sarah Condella, and Kevin T Conroy. The most recent trade was a sale of 5,000 shares reported by JACOB A ORVILLE (EVP, GM, Screening), made on Nov 19, 2025.
History of Insider Stock Trades by Katherine S Zanotti
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EXAS
|
Sale | 12,000 | Oct 24, 2025 | Oct. 27, 2025, 8:35 p.m. |
|
EXAS
|
Sale | 3,207 | Jun 13, 2025 | June 16, 2025, 5:30 p.m. |
|
EXAS
|
Sale | 3,027 | Jun 09, 2023 | June 12, 2023, 4:17 p.m. |
|
EXAS
|
Sale | 4,608 | Jul 26, 2022 | July 28, 2022, 4:04 p.m. |
|
EXAS
|
Sale | 1,086 | Jun 30, 2022 | July 1, 2022, 6:20 p.m. |
CUTR
|
Purchase | 1,307 | Nov 29, 2021 | Dec. 1, 2021, 9:11 a.m. |
|
EXAS
|
Sale | 1,381 | Jul 30, 2021 | Aug. 1, 2021, 8 p.m. |
$EXAS Executives and Stock Owners with Insider Trades
-
Jeffrey Thomas Elliott, Chief Financial Officer
-
Sarah Condella, EVP, Human Resources
-
Kevin T Conroy, President and CEO
-
Jacob A Orville, General Manager, Screening
-
James Herriott, General Counsel
-
Brian Baranick, Gen. Mgr., Precision Oncology
-
Everett Cunningham, Chief Commercial Officer
-
Sarah Condella, SVP, Human Resources
-
Jacob A Orville, General Manager, New Ventures
-
James Herriott, SVP, General Counsel & Sec
-
Brian Baranick, EVP, GM, Precision Oncology
-
D Scott Coward, Chief Administrative Officer
-
Brian Baranick, EVP, GM., Precision Oncology
-
D Scott Coward, Chief Legal Officer
-
Jacob A Orville, EVP, GM, Screening
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.